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A key to the prevention of childhood cancer is the control of carcinogens to which children are exposed. The first step in this process is to identify
those chemicals that are likely to cause cancer in children. The best way to identify carcinogens, today, is the use of the rodent lifetime cancer
test-the bioassay. The test has vocal critics, but is adequately reliable if properly used. Perhaps the major criticism concerns the use of the maxi-
mum tolerated dose as the highest dose tested. Critics claim that this dose causes cellular killing. The resultant cellular proliferation "fixes" preexist-
ing mutations that can lead to cancer. This occurs but in a small fraction of the tests, and the high dose is necessary to achieve statistical sensitivity.
All human carcinogens have been shown, when properly studied, to be carcinogenic in rodents. Many human carcinogens were first shown to
cause cancer in rodent tests. Regulators rarely ban chemicals that have been demonstrated to be carcinogenic. Further, most chemicals in use
today have not been properly tested. The potential errors in the rodent cancer test seem small when compared to the errors in the economic projec-
tions of the effects of restricting chemicals. Although not perfect, the rodent cancer test, when used properly, can help protect our children, and us,
from cancer. - Environ Health Perspect 103(Suppl 6):173-175 (1995)
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The watchword is that prevention is the
key to good health and to a smaller
national health bill. It also is the key to
protecting children from cancer.
The incidence of childhood cancer is
rising while the death rate is decreasing.
Unlike most adult cancer, much ofchild-
hood cancer is fortunately curable, but at a
terrible cost in dollars ($100,000s plus)
and great pain and suffering.
Ifthe causes ofchildhood cancer can be
identified and then controlled, cancer can
often be prevented rather than treated.
Can we use laboratory animal tests to
predict that a chemical will cause cancer in
an exposed human? This is particularly
important because animal tests offer the
only realistic opportunity to detect carcino-
genic chemicals before people are exposed
to them. This concept is the basis for the
1976 Toxic Substances Control Act
(TOSCA). But today it is being severely
challenged by everybody from Ames and
Ableson to The New York Times. I am
particularly distressed by the Times.
Let me, at the outset, make two points.
First, predictions of human health effects
from laboratory animal tests are not per-
fect. But I know of no biological system
that achieves perfection. Prediction of rat
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or mouse carcinogenicity from results in
the other species is greater than 80% (1).
Second, there is no other method available
today that can predict, with precision, car-
cinogenic effects before they occur in the
population.
In general there are three ways to pre-
dict human carcinogenicity for a new
chemical. First is structure-activity rela-
tionships. These work well when dealing
with a chemical from a known series of
chemical moieties. A number ofnew com-
puter-based systems seem quite good. But,
since they are largely dependent on previ-
ous knowledge oftoxicities, they may fail if
a chemical from a completely unknown
series is studied. For example, once it is
known that folic acid antagonists are toxic,
structural predictions do well. But, how is
the first one ofa series predicted?
There was great hope, some years ago,
that short-term tests could screen those
potentially carcinogenic compounds from
all others and that expensive long-term
testing could concentrate on those few. It
does not look as ifthis is possible. A series
of75 chemicals that had been well tested
in long-term mouse and rat studies were
tested in four short-term assays:
Salmonella, the Ames test, and three others
(2). The Salmonella test predicted better
than any other and no combination oftests
was better than that for Salmonella. Ifthe
Salmonella test was positive, the rats and
mice usually were positive. If the
Salmonella test was negative, however,
almost half the chemicals were carcino-
genic. So far these tests can identify
chemicals that are very likely to be carcino-
genic, but can not surely identify ones that
are negative and therefore safe with respect
to carcinogenicity. In the best ofall worlds,
it would be the opposite.
The long-term rodent carcinogenicity
test is the third predictive test. This test is
not without disadvantages. It is expensive
in both time and money. Each complete
test costs hundreds ofthousands ofdollars
and 1000+ hours ofpathologist time. And
it takes at least 9 months to initiate, more
than 24 months to conduct, and another
24 months to analyze and write up. In the
typical test, male and female inbred mice
and rats are used. One group of50 or more
animals is given a high dose, the maximum
tolerated dose (MTD), and two groups are
given lower doses of the test compound.
There is also a control group.
The high dose, the MTD, the highest
dose that causes only minimal toxicity,
which is necessary for maximum statistical
sensitivity, is criticized because it may
cause damage which may lead to cellular
proliferation, increased mitosis, and even-
tually carcinogenicity. There are examples
in which proliferation is implicated in the
carcinogenic response. And these examples
are used as if they are typical. In fact, a
review ofthe 195 long-term tests from the
National Toxicology Program (NTP)
showed that lower dose(s) as well as the
highest dose showed a statistically
significant increase in cancer rates for 2/3
of the chemicals. In about 1/5 of the
chemicals, cancer rates for multiple doses
were increased but not statistically
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significant. Only 6% were truly high dose
only positives. For the vast majority of
chemicals, the high maximum tolerated
dose is not the cause ofcarcinogenicity (3).
Marshall Anderson and his colleagues
have studied oncogene activation in spon-
taneous and chemical-induced mouse and
rat tumors. Two industrial chemicals,
furan and furfural, are carcinogenic in rat
and mouse livers, yet are negative in typical
mutagenicity tests. But the pattern ofacti-
vated oncogenes in the chemically treated
animal liver cancers are qualitatively differ-
ent from those ofthe controls. New onco-
gene mutations were observed: a different
mutation in H-ras and a new K-ras (4).
With methylene chloride, induced liver
tumors had the same oncogenes as the con-
trols, but in the treated excess lung tumors,
different oncogenes were observed (5,6). If
such studies can be performed on human
tumors presumptively caused by chemical
carcinogens, the results can be compared to
those in the experimental studies. I would
expect that the essential similarity between
rodent and human carcinogenicity would
be observed. The advent ofthe widespread
use of the polymerase chain reaction
(PCR), particularly with fixed tissue, will
be enlightening. Imagine the power of
human epidemiology if carcinogens left
footprints!
A number of studies have shown that
carcinogens are active at low doses that do
not cause toxicity, e.g., 1,3-butadiene (7).
Recent studies by Richard Peto and his col-
laborators are interesting and important.
They studied the carcinogenicity of N-
nitrosodiethylamine and N-nitrosodi-
methylamine in rats at doses that ranged
over 2.5 orders of magnitude (0.033-
16.896 ppm in drinking water). Younger
rats were much more susceptible to the car-
cinogens than older rats; rats treated begin-
ning at 2 weeks ofage were 6 to 8 times as
sensitive to the carcinogens as rats treated
beginning at 20 weeks. At doses less than 1
ppm in the diet, the response was linear
with dose, while above that the slope
flattened (8,9).
The question is: How well do rodent
tests predict for humans? First we must
decide on the criteria for a positive test. In
each chemical test male and female rats
and mice are used, thus, four sub-experi-
ments are embedded in each chemical test.
And with dozens of tissues to be catego-
rized for cancer, the possibilities for ran-
dom false positives loom large. The details
of this process are found in every NTP
report. Hasemen at NTP has shown that
the use ofp< 0.01 instead of 0.05 greatly
decreases the chances of a false positive.
Less stringent standards are adequate for
rare tumors. More reliance is placed on
trend tests. Thus, 0, 1, 2, 3, or 4 of the
sub-experiments can be positive. Is a chem-
ical to be called a carcinogen if only one
sub-experiment is positive? What about
two? Certainly ifthree or four are positive,
a call ofcarcinogenicity seems justified. A
single positive is viewed as only suspicious;
two positives suggest a need to look at the
detailed results. Manywho discuss carcino-
gens fail to use such a conservative rating
system and any significant increase in one
subexperiment (one species, one sex, one
organ) is called positive. These persons
often are the ones who suggest that "every-
thing is carcinogenic," or "too many
rodent carcinogens...." The conservative
analysis ofthe results ofthe NTP tests sug-
gests that no more than 20 to 25% are pos-
itive. It should be remembered that many
of the chemicals chosen for study were
already thought to be carcinogens.
How well do the results oflaboratory
animal tests predict for human carcino-
genicity? As noted above, rats and mice
predict for each other better than 80%. No
such answer is possible for humans, since
so few chemicals have been adequately
studied in human populations. It is known,
however, that all human carcinogens that
have been adequately tested have been pos-
itive in animal studies, even arsenic. It has
been claimed that many animal carcino-
gens have been shown not to be carcino-
genic in humans. What has been shown is
that most studies actually have been incon-
clusive because ofsmall sample sizes and/or
because of too low exposures. It is impor-
tant to remember that the lack ofevidence
for carcinogenicity is not evidence for the
lack ofcarcinogenicity!
An NAS NRC (10) study on pesticide
practices examined the quantitative rela-
tionship between the dose in rodents that
caused cancer and the dose in humans that
caused cancer. The dose in humans was
about the same as that in the most sensitive
species for benzidine, chlornaphthazine,
and cigarette smoke. The most sensitive
rodent species was more sensitive to
diethylstillbestrol (DES) and vinyl chloride.
Other more recent studies have shown
essentially similar results.
There are an increasing number ofcases
in which laboratory animal carcinogenicity
studies have predicted human carcino-
genicity before the fact. These include 4-
aminobiphenyl, DES, mustard gas,
bis-(chloromethyl) ether, estrogens, and
vinyl chloride. Recent evidence now sug-
gests that 1,3-butadiene, formaldehyde,
2,3,7,8-tetrachlorodibenzo-p-dioxin, and
dioxin also cause cancer in exposed people.
Oflong-term importance is the confirma-
tion that dioxin is a human carcinogen at
extremely low concentrations (11). The
past regulatory response was that greatly
limited dioxin contamination now seems
appropriate. Old evidence, more recently
unearthed, adds asbestos to that list. In the
discovery process in the asbestos lawsuits, it
was revealed that scientists at the Trudeau
laboratory at Saranac Lake had, in 1942,
shown that asbestos causes lung cancer in
mice (12). But the industrial sponsors of
that research prevented that information
from becoming public. Remember that
Doll published his epic paper in 1955
(13). Would this have made any differ-
ence? Actually, the Saranac Lake results
were discussed at a closed seminar in 1952,
which may have lead to Doll's paper.
It has been claimed that regulatory
agencies over-respond to reports of rodent
carcinogenesis and try to ban any chemical
so implicated. Fortunately, the Congres-
sional Office ofTechnology Assessment
studied that claim (14). They found that
most known rodent carcinogens were not
regulated. The report found many regula-
tory gaps in which many if not most
rodent carcinogens were not regulated and
few ifanywere banned.
The most common assumption is that
all widely used chemicals and processes
have undergone thorough testing. It is not
well known that, in fact, a rather small
fraction of common chemicals, including
food additives, cosmetics, medicines, agri-
cultural chemicals, industrial and other
chemicals have been properly tested for
carcinogenicity. Another NAS NRC report
on toxicity testing estimated that only
about 10% ofpesticides, 5% offood addi-
tives, 18% ofmedicines, and a low percent
ofhigh-volume chemicals had been tested
adequately so that a complete hazard
assessment was possible (15). This finding
was confirmed by a congressional study of
the House Subcommittee on Agriculture,
which found that about 90% ofpesticides
had not been tested for carcinogenicity. A
report by the Organization for Economic
and Commercial Development (OECD)
confirmed that most of the widely used
chemicals had not been adequately tested.
Much attention is paid to the uncer-
tainty in risk estimates, while little is paid
to estimates of economic damage. One
Environmental Health Perspectives 174CANLABORATORYANIMAL CARCINOGENICITYSTUDIES PREDICTCANCERINEXPOSED CHILDREN?
example, albeit an old one, is instructive.
David Dominick was an Assistant
Administrator of U.S. EPA when he was
presented with the problem ofchlorinated
hydrocarbon (a by-product of pesticide
manufacture)-contaminated pasture land
in Louisiana (16). He obtained estimates
from agricultural economists ofthe number
ofcattle that were so heavily contaminated
they would have to be destroyed. The
answer was three. The others, fed clean
diets, had their contaminant levels lowered
enough to be considered marketable. The
health risk versus the economic benefit (or
damage) analysis, therefore, becomes
increasingly murky. And yet there is a great
reluctance to regulate strictly any chemical
with significant economic importance.
Remember the AD Little study of the
potential impact ifvinyl chloride (VC)
were to be strictly regulated (17). They
predicted economic disaster, the loss of 1.7
to 2.2 million jobs, and a decrease of$65
to 90 billion in the GNP. Yet after VC reg-
ulation, there was little impact on the VC
or any other industry. Enclosing the pro-
duction process was costly, but the saving
of5 to 10% ofthe VC production paid for
the effort. And the company that devel-
oped the process made money by licensing
it. Remember also that the entire asbestos
industry was destroyed because of its fail-
ure to protect its workers and its repeated
denial ofhealth hazards.
Economic progress is necessary and
must be supported and protected. At the
same time, care must be used to ensure
that the chemicals and processes used do
not endanger the health ofthe workers or
the general population. To protect these
people and their children, those few critical
toxic chemicals and processes must be
identified, first by animal tests and ifneces-
sary also by epidemiological studies. This
information can then be used to devise sen-
sible regulations to protect the people. This
is not banning; there are many techniques
ofrisk management such as various restric-
tions limiting use or by labeling.
Winston Churchill described democ-
racy as a flawed system, yet the very best
we had, much better than other systems.
Much the same can be said oflong-term
laboratory animal testing for carcinogen
identification, only I do not believe that it
is badly flawed. It is a biological system,
and like all biological systems, it is not per-
fect. It does give important information-
information that, if used wisely, can
prevent the exposure ofpeople to carcino-
gens, eliminate some disease, and save lives.
And there is no alternative.
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